loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Drinabant, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Drinabant

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Temad- We think of world-class quality.

    2D Structure
    1. Also known as: 358970-97-5, Ave-1625, Ave1625, Drinabant [inn], Ave 1625, 61s98rll5i
    Molecular Formula
    C23H20Cl2F2N2O2S
    Molecular Weight
    497.4  g/mol
    InChI Key
    IQQBRKLVEALROM-UHFFFAOYSA-N
    FDA UNII
    61S98RLL5I
    AVE-1625 is an oral selective and potent antagonist of cannabinoid 1 (CB1) receptors having the same mechanism of action as rimonabant. It is currently developed in obesity and its associated comorbidities. AVE-1625 is also being developed for the treatment of Alzheimer disease.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    N-[1-[bis(4-chlorophenyl)methyl]azetidin-3-yl]-N-(3,5-difluorophenyl)methanesulfonamide
    2.1.2 InChI
    InChI=1S/C23H20Cl2F2N2O2S/c1-32(30,31)29(21-11-19(26)10-20(27)12-21)22-13-28(14-22)23(15-2-6-17(24)7-3-15)16-4-8-18(25)9-5-16/h2-12,22-23H,13-14H2,1H3
    2.1.3 InChI Key
    IQQBRKLVEALROM-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CS(=O)(=O)N(C1CN(C1)C(C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl)C4=CC(=CC(=C4)F)F
    2.2 Other Identifiers
    2.2.1 UNII
    61S98RLL5I
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Ave1625

    2.3.2 Depositor-Supplied Synonyms

    1. 358970-97-5

    2. Ave-1625

    3. Ave1625

    4. Drinabant [inn]

    5. Ave 1625

    6. 61s98rll5i

    7. N-[1-[bis(4-chlorophenyl)methyl]azetidin-3-yl]-n-(3,5-difluorophenyl)methanesulfonamide

    8. N-(1-(bis(4-chlorophenyl)methyl)azetidin-3-yl)-n-(3,5-difluorophenyl)methanesulfonamide

    9. Unii-61s98rll5i

    10. Drinabant [who-dd]

    11. Schembl684143

    12. Chembl3545166

    13. Dtxsid50189455

    14. Zinc59299699

    15. Hy-14788

    16. Cs-0003562

    17. 970d975

    18. Q5307675

    19. Methanesulfonamide, N-(1-(bis(4-chlorophenyl)methyl)-3-azetidinyl)-n-(3,5-difluorophenyl)-

    20. N-[1-[bis(4-chlorophenyl)methyl]-3-azetidinyl]-n-(3,5-difluorophenyl)methanesulfonamide

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 497.4 g/mol
    Molecular Formula C23H20Cl2F2N2O2S
    XLogP35.6
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count6
    Exact Mass496.0590608 g/mol
    Monoisotopic Mass496.0590608 g/mol
    Topological Polar Surface Area49 Ų
    Heavy Atom Count32
    Formal Charge0
    Complexity686
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Investigated for use/treatment in alzheimer's disease, obesity, and schizophrenia and schizoaffective disorders.

    5 Pharmacology and Biochemistry
    5.1 Mechanism of Action

    AVE-1625 is a selective and potent antagonist of cannabinoid 1 (CB1) receptors having the same mechanism of action as rimonabant.

    Post Enquiry
    POST ENQUIRY